Here's an analysis of Arteris, Inc. (Ticker: AIP) for everyday investors.

1. The Business Model (How They Make Money)

Arteris, Inc. is like a specialized architect for the tiny, complex cities inside modern computer chips. Instead of building the entire chip, they design the "roads" and "traffic lights" that allow different parts of the chip to communicate efficiently. These "roads" are called Network-on-Chip (NoC) interconnects, and the "traffic lights" are their System-on-Chip (SoC) integration automation software and hardware security tools.

Their customers are not the people who buy phones or computers, but rather the companies that design the chips inside those devices. These include big names in areas like artificial intelligence (AI), self-driving cars, communication systems, and enterprise computing.

Arteris makes money in a few ways:

• Licensing Fees: They charge upfront fees to chip designers who want to use their specialized "road maps" and software in their new chip designs. This is like paying for the blueprint before construction begins.
• Maintenance and Support: After a customer licenses their technology, Arteris provides ongoing support and updates, generating recurring income.
• Professional Services: They offer expert help to customers to integrate their technology into complex chip designs.
• Royalties: This is a key part of their business. Once a customer's chip design goes into mass production and starts shipping, Arteris receives a small payment for each chip sold. This creates a long-term income stream from successful designs.

For the second quarter of 2026, Arteris reported total revenue of $24.1 million. The largest portion, approximately 86%, came from licensing, support, and maintenance, totaling $20.8 million. Variable royalties contributed $2.1 million, and professional services and other revenue accounted for $1.2 million. For the full year 2025, Arteris generated $70.6 million in revenue, with variable royalties making up $6.6 million of that total. The company expects its full-year 2026 revenue to be between $95.0 million and $98.0 million.

2. The Metrics That Matter Most

For Arteris, given its business model of developing and licensing intellectual property for complex chip designs, these are the most important numbers to watch:

• Revenue: This number tells you the total amount of money Arteris brings in from selling its licenses, support, services, and royalties. For a company like Arteris, which is growing rapidly as chip designs become more complex (especially with AI and chiplets), a consistently increasing revenue shows that more chip designers are choosing their technology. It's the most direct measure of how much their "chip architecture" is being adopted in the market. Arteris's revenue grew 46% year-over-year in Q2 2026 to $24.1 million.
• Free Cash Flow: This metric shows how much cash the company generates after paying for its day-to-day operations and necessary investments in its business. For an intellectual property company, which doesn't need to build expensive factories (a "capital-light" business), strong free cash flow indicates that they are efficiently turning their sales into actual cash that can be used for growth, paying down debt (though Arteris has none), or other strategic moves. Arteris reported positive free cash flow of $8.6 million in Q2 2026. For the full year 2025, their non-GAAP free cash flow was positive $5.3 million.
• R&D Expenses (Research & Development Expenses): This represents the money Arteris spends on creating new and improved "chip architecture" and software. As an IP company, innovation is their lifeblood. High and consistent R&D spending is crucial because it shows they are investing in staying ahead of the curve, developing the next generation of technology that chip designers will need. This directly fuels their future licensing and royalty revenue. While specific 2025/2026 R&D numbers were not explicitly broken out in the provided snippets, the nature of their business implies this is a critical investment.
• Net Income: This is the company's profit after all expenses, including taxes, have been paid. While Arteris is currently investing heavily for growth and has reported net losses, tracking this metric over time is important. As the company matures and its royalty streams grow, investors will want to see a clear path towards consistent profitability. In Q2 2026, Arteris reported a net loss of $14.1 million, or $0.30 per share. For the full year 2025, the net loss was $34.7 million, or $0.82 per share.

3. How to Value This Company

For a company like Arteris, which is growing quickly but currently reporting net losses due to heavy investments in its future, the P/Sales (Price-to-Sales) ratio is often the most relevant valuation metric.

Here's why:

• What it is: The P/Sales ratio compares the company's total stock market value (its "market capitalization") to its total revenue over the past year. In simple terms, it tells you how much investors are willing to pay for each dollar of the company's sales.
• Why it's best for Arteris: Since Arteris is currently not making a profit (it has a negative net income), traditional valuation metrics like the P/E (Price-to-Earnings) ratio, which relies on positive earnings, wouldn't be useful. P/Sales allows you to value the company based on its ability to generate revenue, which is a strong indicator of its market adoption and future potential, especially for a growth company in a high-tech sector like semiconductor IP. A higher P/Sales ratio generally means investors expect strong future growth, while a lower ratio might suggest the stock is undervalued relative to its sales, or that growth expectations are lower. You would compare Arteris's P/Sales ratio to similar, publicly traded semiconductor IP or software companies to see if its stock is considered cheap or expensive.